The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 21, 2023

Filed:

Dec. 14, 2017
Applicants:

The J. David Gladstone Institutes, a Testamentary Trust Established Under the Will of J. David Gladstone, San Francisco, CA (US);

The Regents of the University of California, Oakland, CA (US);

Inventors:

Leor S. Weinberger, Oakland, CA (US);

Timothy J. Notton, San Francisco, CA (US);

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/10 (2006.01); C12Q 1/6806 (2018.01); C12Q 1/6869 (2018.01); C12N 15/66 (2006.01); C12N 15/867 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1082 (2013.01); C12N 15/10 (2013.01); C12N 15/1065 (2013.01); C12N 15/66 (2013.01); C12Q 1/6806 (2013.01); C12Q 1/6869 (2013.01); C12N 15/1093 (2013.01); C12N 15/867 (2013.01); C12N 2310/533 (2013.01); C12N 2740/16021 (2013.01); C12N 2740/16062 (2013.01); C12N 2800/107 (2013.01); C12N 2800/80 (2013.01); C12N 2800/90 (2013.01); C12Q 2563/185 (2013.01);
Abstract

Provided are methods and compositions for generating a deletion library, and methods and compositions for generating and identifying a defective interfering particle (DIP). Also provided are transposon cassettes. A subject method can include: inserting a transposon cassette comprising a target sequence for a sequence specific DNA endonuclease into a population of circular target DNAs to generate a population of transposon-inserted circular target DNAs; contacting the population of transposon-inserted circular target DNAs with the sequence specific DNA endonuclease to generate a population of cleaved linear target DNAs; contacting the population of cleaved linear target DNAs with one or more exonucleases to generate a population of deletion DNAs; and circularizing the deletion DNAs to generate a library of circularized deletion DNAs. The population of circular target DNAs can include viral genomic DNA. Also provided are human immunodeficiency virus (HIV) deletion mutants, e.g., interfering, conditionally replicating, HIV deletion mutants, and related constructs.


Find Patent Forward Citations

Loading…